annb0t
Top 20
Opthea Limited
Key appointment as Opthea progresses Phase 3 registrational trials of OPT-302 for wet AMD
MELBOURNE, Australia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, is pleased to announce the appointment of Timothy E. Morris as Chief Financial Officer (CFO), effective 24 October 2022. Mr. Morris is a veteran pharmaceutical executive...
>>> Read more: Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as Chief Financial Officer
Key appointment as Opthea progresses Phase 3 registrational trials of OPT-302 for wet AMD
MELBOURNE, Australia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, is pleased to announce the appointment of Timothy E. Morris as Chief Financial Officer (CFO), effective 24 October 2022. Mr. Morris is a veteran pharmaceutical executive...
>>> Read more: Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as Chief Financial Officer
